These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1095 related articles for article (PubMed ID: 30639476)
1. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells. Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476 [TBL] [Abstract][Full Text] [Related]
2. SENP2 alleviates CCl Bu FT; Chen Y; Yu HX; Chen X; Yang Y; Pan XY; Wang Q; Wu YT; Huang C; Meng XM; Li J Toxicol Lett; 2018 Jun; 289():86-98. PubMed ID: 29535048 [TBL] [Abstract][Full Text] [Related]
3. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890 [TBL] [Abstract][Full Text] [Related]
4. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells. Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935 [TBL] [Abstract][Full Text] [Related]
5. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling. Perumal N; Perumal M; Halagowder D; Sivasithamparam N Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397 [TBL] [Abstract][Full Text] [Related]
6. Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal. Lee EH; Park KI; Kim KY; Lee JH; Jang EJ; Ku SK; Kim SC; Suk HY; Park JY; Baek SY; Kim YW Phytomedicine; 2019 Sep; 62():152780. PubMed ID: 31121384 [TBL] [Abstract][Full Text] [Related]
7. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway. Yang YR; Bu FT; Yang Y; Li H; Huang C; Meng XM; Zhang L; Lv XW; Li J Mol Immunol; 2020 Oct; 126():31-39. PubMed ID: 32745796 [TBL] [Abstract][Full Text] [Related]
8. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury. Konishi T; Schuster RM; Lentsch AB Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389 [TBL] [Abstract][Full Text] [Related]
9. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling. Wu SM; Li TH; Yun H; Ai HW; Zhang KH Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340 [TBL] [Abstract][Full Text] [Related]
10. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl Liu QQ; Chen J; Ma T; Huang W; Lu CH Sci Rep; 2024 Apr; 14(1):9425. PubMed ID: 38658618 [TBL] [Abstract][Full Text] [Related]
11. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis. Yang Y; Chen XX; Li WX; Wu XQ; Huang C; Xie J; Zhao YX; Meng XM; Li J J Cell Mol Med; 2017 Oct; 21(10):2317-2328. PubMed ID: 28332284 [TBL] [Abstract][Full Text] [Related]
12. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation. Li L; Zhou J; Li Q; Xu J; Qi J; Bian H Biomed Pharmacother; 2018 Oct; 106():83-91. PubMed ID: 29957470 [TBL] [Abstract][Full Text] [Related]
13. CD73 regulates hepatic stellate cells activation and proliferation through Wnt/β-catenin signaling pathway. Jia WQ; Zhou TC; Dai JW; Liu ZN; Zhang YF; Zang DD; Lv XW Eur J Pharmacol; 2021 Jan; 890():173667. PubMed ID: 33121948 [TBL] [Abstract][Full Text] [Related]
14. Experimental study on H Bai Y; Liu F; Luo S; Wan Y; Zhang L; Wu X; Chen Q; Xie Y; Guo P J Ethnopharmacol; 2024 Dec; 335():118712. PubMed ID: 39173724 [TBL] [Abstract][Full Text] [Related]
15. PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β-catenin signalling pathway. Chen Y; Chen X; Ji YR; Zhu S; Bu FT; Du XS; Meng XM; Huang C; Li J J Cell Mol Med; 2020 Jul; 24(13):7405-7416. PubMed ID: 32463161 [TBL] [Abstract][Full Text] [Related]
16. Cordycepin alleviates hepatic fibrosis in association with the inhibition of glutaminolysis to promote hepatic stellate cell senescence. Liang Z; Zhang K; Guo H; Tang X; Chen M; Shi J; Yang J Int Immunopharmacol; 2024 May; 132():111981. PubMed ID: 38565039 [TBL] [Abstract][Full Text] [Related]
17. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581 [TBL] [Abstract][Full Text] [Related]
18. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a. Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384 [TBL] [Abstract][Full Text] [Related]
19. TIPE2 attenuates liver fibrosis by reversing the activated hepatic stellate cells. Xu DD; Li XF; Li YH; Liu YH; Huang C; Meng XM; Li J Biochem Biophys Res Commun; 2018 Mar; 498(1):199-206. PubMed ID: 29196266 [TBL] [Abstract][Full Text] [Related]
20. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways. Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]